Phase I study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL) Meeting Abstract

  

Authors:	Grommes, C.; Kaley, T. J.; Nolan, C.; Omuro, A. M. P.; Wolfe, J.; Mellinghoff, I. K.; DeAngelis, L. M.
Abstract Title:	Phase I study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	104s
Language:	English
ACCESSION:	WOS:000404665403034
DOI:	10.1200/JCO.2016.34.15_suppl.2046
PROVIDER:	wos
Notes:	Meeting Abstract: 2046 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/154949